Skip to main content
OpenTrials

Clinical trial condition

Histiocytosis

Explore clinical trials studying Histiocytosis. Study availability and eligibility vary by location and protocol.

406 public trials 82 recruiting studies
Refine in advanced search Browse all conditions

Histiocytosis trial results

Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

NCT05828069

Conditions
Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +6 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
View all 120 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis

NCT07054515

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +25 more
Locations
  • UCSF Children's Hospital and Research Center at Oakland Oakland, California, United States
  • University of Minnesota Medical School Minneapolis, Minnesota, United States
  • Mayo Clinic Childrens Center - PIN Rochester, Minnesota, United States
  • Children's Medical Center Dallas Dallas, Texas, United States
View all 39 locations
View Trial Details
Recruiting

Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell Lymphoma

NCT06220032

Conditions
Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +22 more
Locations
  • NL-Den Bosch-JBZ 's-Hertogenbosch, Netherlands
  • NL-Almelo-ZGTALMELO Almelo, Netherlands
  • NL-Amstelveen-AMSTELLAND Amstelveen, Netherlands
  • NL-Apeldoorn-GELREAPELDOORN Apeldoorn, Netherlands
View all 25 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC)

NCT07082725

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +20 more
Locations
  • UCSF Children's Hospital and Research Center at Oakland Oakland, California, United States
  • University of Minnesota Medical School Minneapolis, Minnesota, United States
  • Mayo Clinic Children's Center - PIN Rochester, Minnesota, United States
  • Children's Medical Center Dallas Dallas, Texas, United States
View all 34 locations
View Trial Details
Recruiting

Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)

NCT06160791

Conditions
Hemic and Lymphatic Diseases, Hemophagocytic Lymphohistiocytoses, Histiocytosis, +3 more
Locations
  • University of California, Irvine Irvine, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of California, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
View Trial Details
Recruiting

A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency (ASMD)

NCT06192576

Conditions
Acid Sphingomyelinase Deficiency, Brain Diseases, Brain Diseases, Metabolic, +19 more
Locations
  • Ann and Robert H Lurie Children's Hospital of Chicago- Site Number: 001002 Chicago, Illinois, United States
  • Children's Hospital Medical Center- Site Number: 001003 Cincinnati, Ohio, United States
  • Pulse InfoFrame US Inc.- Site Number: 001001 Philadelphia, Pennsylvania, United States
  • Dell Children's Medical Center- Site Number : 1001-2 Austin, Texas, United States
View Trial Details

Related conditions